ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,897,250 | -51.4% | 48,007 | -50.6% | 0.23% | -75.2% |
| Q3 2022 | $3,904,000 | -4.4% | 97,173 | 0.0% | 0.93% | +83.0% |
| Q2 2022 | $4,085,000 | +10.8% | 97,173 | +2.6% | 0.51% | +25.5% |
| Q1 2022 | $3,688,000 | -2.3% | 94,673 | 0.0% | 0.40% | -16.4% |
| Q4 2021 | $3,773,000 | +13.9% | 94,673 | +3.3% | 0.48% | +6.9% |
| Q3 2021 | $3,312,000 | -11.8% | 91,641 | +0.0% | 0.45% | -0.4% |
| Q2 2021 | $3,756,000 | -6.0% | 91,640 | 0.0% | 0.45% | +19.5% |
| Q1 2021 | $3,997,000 | -14.7% | 91,640 | -2.1% | 0.38% | -39.4% |
| Q4 2020 | $4,687,000 | – | 93,640 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |